文献速递心外重症与机械循环支持

心脏术后心源性休克体外膜氧合支持的长期结局

Long-term outcomes of extracorporeal membrane oxygenation support for postcardiotomy shock.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-03-11

基于台湾全民健康保险研究数据库,2000至2011年共识别1141例心脏术后接受ECMO的患者,并按倾向评分匹配5倍非ECMO心脏手术患者。ECMO组院内死亡率显著更高(61.7% vs 6.8%,OR 22.34,95%CI 19.06-26.18),但随访一年后全因死亡与再入院风险两组无差异。

要点

  • 心脏术后ECMO使用率为1.91%。
  • ECMO组院内死亡风险显著高于非ECMO组(OR 22.34)。
  • 随访超过一年后两组死亡与再入院风险无差异。

核心结论

  • 心脏术后因心源性休克接受ECMO的患者院内结局显著较差,但随访一年后结局与非ECMO组相似。

研究设计与样本

  • 基于台湾全民健康保险研究数据库的回顾性队列研究,纳入2000至2011年心脏术后接受ECMO的1141例患者,按倾向评分1:5匹配非ECMO心脏手术患者。

主要发现

  • ECMO组院内死亡率为61.7%,非ECMO组为6.8%,比值比22.34(95%CI 19.06-26.18)。
  • 随访第一年内ECMO组全因死亡风险(P < .001)和首次再入院风险(P < .001)均高于对照组。
  • 随访一年后两组全因死亡风险(P = .209)和再入院风险(P = .474)无差异。
  • 指数住院出院后医疗费用在一年后两组结果相似。

关键数值与推荐

  • 心脏术后ECMO使用率为1.91%。
  • 院内死亡比较:ECMO组61.7% vs 非ECMO组6.8%,OR 22.34(95%CI 19.06-26.18)。
  • 一年后全因死亡风险组间比较P = .209,再入院风险比较P = .474。

临床怎么用

  • 心脏术后心源性休克患者接受ECMO虽院内风险高,但存活出院后一年以上结局与非ECMO患者相近,可据此进行远期预后咨询。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Extracorporeal membrane oxygenation (ECMO) is a widely used technique for treating postcardiotomy cardiogenic shock (PCS); however, no study has compared the long-term outcomes of patients who receive ECMO support for PCS with those of the general population post cardiac surgery. METHODS: A total of 1141 patients who received ECMO after cardiac surgery between 2000 and 2011 were identified by using the Taiwan National Health Insurance Research Database. For each patient, we matched 5 non-ECMO patients who had undergone cardiac surgery by using propensity scores calculated for age, sex, 12 comorbid diseases, Charlson score, hospital level, type of cardiac surgery, and year of index hospitalization. The outcomes included all-cause mortality, readmission for any cause, and medical expenditure. RESULTS: The incidence of ECMO use after cardiac surgery in Taiwan was 1.91%. The ECMO group had a significantly higher risk of in-hospital mortality than did the non-ECMO group (61.7% vs 6.8%, odds ratio 22.34, 95% confidence interval 19.06-26.18). The risks of all-cause mortality and first readmission for any cause were greater in the ECMO group than that in the control group (P < .001, P < .001) in the first year, whereas no difference was observed after the first year of follow-up (P = .209, P = .474). Similar results were observed regarding the medical expenditure of admission after index admission discharge. CONCLUSIONS: Patients receiving ECMO for PCS had similar outcomes to those of the non-ECMO group after the first year of follow-up despite significantly poor outcomes during the in-hospital course.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Chen SW, Tsai FC, Lin YS, et al. Long-term outcomes of extracorporeal membrane oxygenation support for postcardiotomy shock. J Thorac Cardiovasc Surg. 2017. PMID: 28413074. doi:10.1016/j.jtcvs.2017.02.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。